KIORA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
KIORA PHARMACEUTICALS, INC. (KPRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 10 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 0.00 shares.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 10.00 shares, a 62.96% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 7.00 shares, a 133.33% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 34.00 shares, a 97.64% decline from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 1.44K shares, a 1314.71% increase from fiscal 2023.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 102.00 shares, a 628.57% increase from fiscal 2022.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 14.00 shares, a 98.30% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 10.00 shares 10-Q · filed 2026-08-07 | 10.00 shares derived: sum of 3 quarters · filed 2026-08-07 | 17.00 shares derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | 10.00 shares 10-Q · filed 2026-05-08 | 10.00 shares derived: sum of 2 quarters · filed 2026-05-08 | 17.00 shares derived: sum of 3 quarters · filed 2026-05-08 | 17.00 shares derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 7.00 shares derived: sum of 2 quarters · filed 2026-03-25 | 7.00 shares derived: sum of 3 quarters · filed 2026-03-25 | 34.00 shares 10-K · filed 2026-03-25 | ||
| 2025-09-30 | 7.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 7.00 shares derived: sum of 2 quarters · filed 2025-11-07 | 34.00 shares 10-Q · filed 2025-11-07 | 1.05K shares derived: sum of 4 quarters · filed 2026-03-25 | ||
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 27.00 shares 10-Q · filed 2025-08-08 | 1.04K shares derived: sum of 3 quarters · filed 2026-03-25 | 1.05K shares derived: sum of 4 quarters · filed 2026-03-25 | ||
| 2025-03-31 | 27.00 shares 10-Q · filed 2025-05-09 | 1.04K shares derived: sum of 2 quarters · filed 2026-03-25 | 1.05K shares derived: sum of 3 quarters · filed 2026-03-25 | 767.00 shares derived: sum of 4 quarters · filed 2026-03-25 | ||
| 2024-12-31 | 1.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 1.02K shares derived: sum of 2 quarters · filed 2026-03-25 | 740.00 shares derived: sum of 3 quarters · filed 2026-03-25 | 1.44K shares 10-K · filed 2026-03-25 | ||
| 2024-09-30 | 3.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -277.00 shares derived: sum of 2 quarters · filed 2024-11-08 | 426.00 shares 10-Q · filed 2024-11-08 | 111.00 shares derived: sum of 4 quarters · filed 2025-03-25 | ||
| 2024-06-30 | -280.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 423.00 shares 10-Q · filed 2024-08-09 | 108.00 shares derived: sum of 3 quarters · filed 2025-03-25 | 481.00 shares derived: sum of 4 quarters · filed 2025-03-25 | ||
| 2024-03-31 | 703.00 shares 10-Q · filed 2024-05-10 | 388.00 shares derived: sum of 2 quarters · filed 2025-03-25 | 761.00 shares derived: sum of 3 quarters · filed 2025-03-25 | 761.00 shares derived: sum of 4 quarters · filed 2025-03-25 | ||
| 2023-12-31 | -315.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | 58.00 shares derived: sum of 2 quarters · filed 2025-03-25 | 58.00 shares derived: sum of 3 quarters · filed 2025-03-25 | 102.00 shares 10-K · filed 2025-03-25 | 927.00 shares 10-K · filed 2024-03-25 | |
| 2023-09-30 | 373.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 373.00 shares derived: sum of 2 quarters · filed 2023-11-09 | 417.00 shares 10-Q · filed 2023-11-09 | -6.39K shares derived: sum of 4 quarters · filed 2024-03-25 | ||
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 44.00 shares 10-Q · filed 2023-08-08 | -6.76K shares derived: sum of 3 quarters · filed 2024-03-25 | -138.47K shares derived: sum of 4 quarters · filed 2024-03-25 | ||
| 2023-03-31 | 44.00 shares 10-Q · filed 2023-05-09 | -6.76K shares derived: sum of 2 quarters · filed 2024-03-25 | -138.47K shares derived: sum of 3 quarters · filed 2024-03-25 | -12.60K shares derived: sum of 4 quarters · filed 2024-03-25 | ||
| 2022-12-31 | -6.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -138.51K shares derived: sum of 2 quarters · filed 2024-03-25 | -12.65K shares derived: sum of 3 quarters · filed 2024-03-25 | 14.00 shares 10-K · filed 2024-03-25 | ||
| 2022-09-30 | -131.71K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -5.84K shares derived: sum of 2 quarters · filed 2022-11-09 | 6.82K shares 10-Q · filed 2022-11-09 | 6.61K shares derived: sum of 4 quarters · filed 2023-03-23 | ||
| 2022-06-30 | 125.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 138.53K shares 10-Q · filed 2022-08-12 | 138.32K shares derived: sum of 3 quarters · filed 2023-03-23 | 131.75K shares derived: sum of 4 quarters · filed 2023-03-23 | ||
| 2022-03-31 | 12.66K shares 10-Q · filed 2022-07-08 | 12.45K shares derived: sum of 2 quarters · filed 2023-03-23 | 5.89K shares derived: sum of 3 quarters · filed 2023-03-23 | 6.38K shares derived: sum of 4 quarters · filed 2023-03-23 | ||
| 2021-12-31 | -210.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -6.77K shares derived: sum of 2 quarters · filed 2023-03-23 | -6.28K shares derived: sum of 3 quarters · filed 2023-03-23 | 825.00 shares 10-K · filed 2023-03-23 | 32.54K shares 10-K · filed 2022-04-15 | |
| 2021-09-30 | -6.56K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -6.07K shares derived: sum of 2 quarters · filed 2022-11-09 | 1.03K shares 10-Q · filed 2022-11-09 | 13.88K shares 10-Q · filed 2021-11-15 | 1.03K shares derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | 496.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 7.60K shares 10-Q · filed 2022-08-12 | 7.60K shares derived: sum of 3 quarters · filed 2022-08-12 | 7.60K shares derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | 7.10K shares 10-Q · filed 2021-05-12 | 7.10K shares derived: sum of 2 quarters · filed 2022-07-07 | 7.10K shares derived: sum of 3 quarters · filed 2022-07-07 | 24.22K shares derived: sum of 4 quarters · filed 2022-07-07 | ||
| 2020-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | 0.00 shares derived: sum of 2 quarters · filed 2022-07-07 | 17.11K shares derived: sum of 3 quarters · filed 2022-07-07 | 17.11K shares 10-K/A · filed 2022-07-07 | ||
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 17.11K shares derived: sum of 2 quarters · filed 2021-11-15 | 17.11K shares 10-Q · filed 2021-11-15 | 31.96K shares derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | 17.11K shares 10-Q · filed 2021-08-12 | 17.11K shares 10-Q · filed 2020-08-06 | 31.96K shares derived: sum of 3 quarters · filed 2021-08-12 | -13.54K shares derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | 8.81K shares 10-Q · filed 2021-05-12 | 14.85K shares derived: sum of 2 quarters · filed 2021-05-12 | -30.65K shares derived: sum of 3 quarters · filed 2021-05-12 | 14.85K shares derived: sum of 4 quarters · filed 2021-05-12 | ||
| 2019-12-31 | 6.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -39.46K shares derived: sum of 2 quarters · filed 2021-03-25 | 6.04K shares derived: sum of 3 quarters · filed 2021-03-25 | 9.27K shares 10-K · filed 2021-03-25 | ||
| 2019-09-30 | -45.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-07 | 3.24K shares 10-Q · filed 2019-11-07 | 6.08K shares derived: sum of 4 quarters · filed 2020-11-09 | ||
| 2019-06-30 | 45.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 48.74K shares 10-Q · filed 2019-08-08 | 51.58K shares derived: sum of 3 quarters · filed 2020-11-09 | -1.71K shares derived: sum of 4 quarters · filed 2020-11-09 | ||
| 2019-03-31 | 3.24K shares 10-Q · filed 2020-11-09 | 6.08K shares derived: sum of 2 quarters · filed 2020-11-09 | -47.20K shares derived: sum of 3 quarters · filed 2020-11-09 | |||
| 2018-12-31 | 2.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -50.44K shares derived: sum of 2 quarters · filed 2020-03-04 | 10.53K shares 10-K · filed 2020-03-04 | |||
| 2018-09-30 | -53.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 7.68K shares 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | 60.97K shares 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |